News and Announcements
Intermin First Ore Produced at Teal
- Published April 27, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Intermin Resources Limited (ASX:IRC) is pleased to provide the March 2017 Quarterly Activities Report. Intermin is a gold exploration and development company with a key focus in the Kalgoorlie region of Western Australia.
KEY TAKEAWAYS:
- Ore mining commenced at the Teal open pit gold mine
- High rainfall in the region resulted in two wall slips at Teal requiring remedial work
- Excellent new drilling results released from December Quarter drilling programs
- Teal gold project Mineral Resource estimate increased 120% to 159,386 ounces
- Goongarrie Lady gold project scoping study complete with positive economic results
- Anthill golf project acquired on the highly prospective Zuleika Shear with significant potential for the definition of a substantial Mineral Resource.
- Joint venture partners commenced field programs at the Richmond Vanadium, Nanadie, Well copper-gold-PGE and Binduli gold projects.
- Cash and tradeable securities of A$4M
JUNE QUARTER ACTIVITIES
- Continued ore mining, haulage, processing and cash flow from Teal.
- Commencement of Resource definition, extension and new discover drill programs
- Engineering and approvals work as part of the Goongarrie Lady Feasibility Study
Intermin is a gold exploration and mining company focussed on the Kalgoorlie and Menzies areas of Western Australia which are host to some of Australia’s richest gold deposits. The Company is developing a mining pipeline of projects to generate cash and self-fund aggressive exploration, mine developments and further acquisitions.
To view the reports, click on the links below.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
